

Welcome to the Radboudumc Community for Infectious Diseases (RCI)
The Radboudumc Community for Infectious Diseases (RCI) brings together healthcare professionals and scientists who are committed to advancing the fight against infectious diseases.
read moreWelcome to the Radboudumc Community for Infectious Diseases (RCI)
Infectious diseases remain one of the most pressing global public health challenges. From tropical infections like malaria and dengue to global pandemics such as COVID-19, and the growing threat of antimicrobial resistance: these conditions continue to impact individuals, communities, and healthcare systems worldwide.
The Radboudumc Community for Infectious Diseases (RCI) brings together healthcare professionals and scientists who are committed to advancing the fight against infectious diseases. Within our learning environment, we adopt an integrated approach that spans infection prevention, diagnostics, treatment, care, research, and education. We aim to develop innovative solutions and improve diagnostics, therapies, and control strategies.
RCI focuses on three core pillars:
- Care: Delivering high-quality, patient-centered care with particular expertise in tropical and complex infections.
- Research: Conducting cutting-edge studies on antimicrobial resistance, novel treatments, and preventive strategies.
- Education: Equipping future healthcare professionals with the skills and knowledge to meet tomorrow’s infectious disease challenges.
Through collaboration and knowledge sharing, we join forces to reduce the impact of infectious diseases and contribute to a healthier society.
Join our community and help shape the future of infectious disease care and research.
-
How our fungal research leads to parliamentary questions18 april 2025
-
Christine Mohrmann Stipend for ten female PhD candidatesAward for Radboudumc PhD candidates Laura Akkerman and Natalie Nielsen4 april 2025
-
Western diet causes inflammation, traditional African food protectsStudy from Tanzania shows major impact of diet on the immune system3 april 2025
SPICE: Expert Registry
The Specialized Program for Infectious Disease Care Everywhere (SPICE) is an expert registry for providing expert consultancy and support matched to the need of healthcare sector in LMICs to ensure standardized and integrated infectious diseases (ID) care.
read more
RCI Science Day 2025 12th of June
9.00 to 17.30 at Hotel Van der Valk, Lent.
Patient care Infectious Diseases
High-quality patient care is central to the Radboud Community Infectious Diseases of Radboudumc.
We offer specialized care for patients with complex and rare infectious diseases, where personal treatment and innovation go hand in hand.
Our expert areas

HIV human immunodeficiency virus
Radboudumc is one of the 26 HIV treatment centers in the Netherlands read more
Lyme disease
Radboud university medical center, the RIVM, the Amsterdam UMC, and the Lyme Association make up the Dutch Lyme Disease expertise center. read more
Mycobacterial infectious diseases Tuberculosis and non-tuberculous mycobacteria (NTM)
Radboud university medical center is a nationally recognized expertise center for tuberculosis and NTM.
read more
Orthopedic infections
Radboud university medical center is one of the national centers designated for the treatment of patients with complex orthopedic prosthesis infections, particularly infections of hip and knee prosthetics. We fulfill a regional and national referral function. read more
Outbreak Management care of very infectious patients
We use our expertise in caring for very infectious patients at Radboud university medical center. We also participate in national advisory bodies and play a coordinating role in outbreaks across the world. read more
Fungal infections
Radboud university medical center, together with CWZ, is a recognized expertise center in the field of fungal infections.
read more (in Dutch)
Antimicrobial Stewardship and Infection Prevention
We focus on to the development and implementation of (cost)effective, timely, safe, and person-centered diagnostics, antimicrobial therapy and infection prevention measures for patients with -a risk of- an infectious disease.
read moreAntimicrobial Stewardship and Infection Prevention
We focus on to the development and implementation of (cost)effective, timely, safe, and person-centered diagnostics, antimicrobial therapy and infection prevention measures for patients with -a risk of- an infectious disease. We are committed to improve patient care safely in order to achieve the best patient outcomes.
With the ultimate aim of curbing antimicrobial resistance, the research focus is on everyday patient problems - both in high and low resource settings - to have global impact. Providing the evidence for appropriate patient care.
Antimicrobial resistance (AMR) is considered a global health threat as infections become more difficult to treat. There are two cornerstones of reducing the development of AMR: Antimicrobial Stewardship and Infection Prevention. The Radboudumc Community for Infectious Diseases (RCI) has always played an important role in the area of AMR, both nationally and internationally.
Our research focuses on the following main questions:
- What innovative diagnostic, antimicrobial therapy or infection prevention measure improves patient outcomes, reduces costs and/or limits the development of antimicrobial resistance?
- How can these evidence-based interventions be implemented into daily practice?
Innovative diagnostics, antimicrobial therapies and infection prevention measures
This research represents the development and clinical testing of innovative diagnostics, antimicrobial therapy or infection prevention measures. This ‘man’-based research provides scientific evidence for the added value of the tested interventions.
Implementation of evidence-based interventions into daily practice
This behavioural research aims at the development and testing of innovative implementation strategies to introduce evidence-based interventions in daily practice. We explore the gap between evidence and practice and its determinants. The latter information is crucial when designing implementation strategies aimed at improving care. This ‘population’-based research provides scientific evidence for the added value of the tested improvement interventions.